Millennium Management
RVMD icon

Millennium Management’s Revolution Medicines RVMD Stock Holding History

Millennium Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-71,200
Closed -$2.04M – 6575
2023
Q4 		$2.04M Buy
+71,200
New +$1.71M ﹤0.01% 3587
2023
Q3 		– Sell
-30,000
Closed -$803K – 6497
2023
Q2 		$803K Buy
+30,000
New +$736K ﹤0.01% 4208
2022
Q4 		– Sell
-50,100
Closed -$988K – 6980
2022
Q3 		$988K Buy
+50,100
New +$1.1M ﹤0.01% 4357

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Millennium Management's RVMD Position: Q1 2026 in Review

Millennium Management reduced its Revolution Medicines (RVMD) stake by 53% in Q1 2026, selling an estimated $42.7M and leaving 377,332 shares worth $36.7M. The position accounts for 0.02% of the portfolio, ranked #1069.

Millennium Management first reported a position in RVMD in Q1 2020 and has held it in 20 quarters since. The position peaked at $63.7M in Q4 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Millennium Management held 377,332 shares of Revolution Medicines worth $36.7M as of Q1 2026.
  • Millennium Management sold 422,786 Revolution Medicines shares in Q1 2026, an estimated $42.7M.
  • Revolution Medicines made up 0.02% of Millennium Management's portfolio in Q1 2026, its #1069 holding.
  • Millennium Management first reported a position in Revolution Medicines in Q1 2020 and has held it in 20 quarters since.
  • Millennium Management's Revolution Medicines position peaked at $63.7M in Q4 2025.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.